Practically all low molecular weight surfactants show hemolytic activi
ties. Aside of this serious disadvantage,almost all low molecular weig
ht solubilizers cause considerable side effects, particularly during o
r after parenteral application. Polymeric surfactants, however, usuall
y show no or only very little hemolytic effects. They therefore are su
pposed not to be able to penetrate neither into cellular or erythrocyt
e walls nor into phospholipid bilayers, resp.,similar bilayer membrane
s due to their large molecular size. Therefore no decay of biological
bilayers should be expected with polymeric surfactants. The only pharm
aceutically widely used polymeric surfactants are at the moment polyox
yethylene-polyoxypropylene block copolymers (poloxamers (INN), Pluroni
cs(R) and Pluriols(R)). Unfortunately they have only poor solubility c
apacities. In order to find better solubilizing polymeric surfactants,
some water soluble dextran fatty acid esters (Ref. 1) were synthesize
d and tested with respect to their solubilisation capacity and hemolyt
ic activity. Usually the hemolytic activity is tested by standard meth
ods using purified animal or human erythrocyte suspensions. As erythro
cytes also contain a relatively high amount of lactose dehydrogenase (
LDH), we studied the suitability of the highly sensitive, and in the m
edical diagnostic well known LDH test, as a supplemental hemolytic det
ermination method (Ref. 2). The advantage of this test is, that there
is no need of the time consuming purification and standardization as i
t is required with the erythrocytes' suspension. It can be performed w
ith original blood and without costly preparations at all. The synthes
ized dextran fatty acid esters proved themselves as very little hemoly
tic and, compared with the polyoxyethylene-polyoxypropylene block copo
lymers, they show improved solubilisation capacities.